E2F4 and E2F1 Have Similar Proliferative Properties but Different Apoptotic and Oncogenic Properties In Vivo

REFERENCES

• Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., and Vousden, K. H.. 1998. p14ARF links the tumour suppressors RB and p53. Nature 395:124–125 (Letter.)
   PubMed Web of Science ®Google Scholar
• Beijersbergen, R. L., Kerkhoven, R. M., Zhu, L., Carlee, L., Voorhoeve, P. M., and Bernards, R.. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680–2690
   PubMed Web of Science ®Google Scholar
• DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J. R.. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245–7250
   PubMed Web of Science ®Google Scholar
• Dover, R., and Wright, N. A.. The cell proliferation kinetics of the epidermis Physiology, biochemistry, and molecular biology of the skin Goldsworth, L. A. 1:239–265 Oxford University Press, New York, N.Y
   Google Scholar
• Dynlacht, B. D., Moberg, K., Lees, J. A., Harlow, E., and Zhu, L.. 1997. 1991. Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Cell. Biol. 17:3867–3875
   PubMed Web of Science ®Google Scholar
• Dyson, N.. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262
   PubMed Web of Science ®Google Scholar
• Ginsberg, D., Vairo, G., Chittenden, T., Xiao, Z. X., Xu, G., Wydner, K. L., DeCaprio, J. A., Lawrence, J. B., and Livingston, D. M.. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665–2679
   PubMed Web of Science ®Google Scholar
• Ikeda, M., Orimo, H., Moriyama, H., Nakajima, E., Matsubara, N., Mibu, R., Tanaka, N., Shimada, T., Kimura, A., and Shimizu, K.. 1998. Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability. Cancer Res. 58:594–598
   PubMedGoogle Scholar
• Ikeda, M. A., Jakoi, L., and Nevins, J. R.. 1996. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA 93:3215–3220
   PubMedGoogle Scholar
• Johnson, D. G.. 1995. Regulation of E2F-1 gene expression by p130(Rb2) and D-type cyclin kinase activity. Oncogene 11:1685–1692
   PubMed Web of Science ®Google Scholar
• Johnson, D. G., Cress, W. D., Jakoi, L., and Nevins, J. R.. 1994. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91:12823–12827
   PubMed Web of Science ®Google Scholar
• Lindeman, G. J., Gaubatz, S., Livingston, D. M., and Ginsberg, D.. 1997. The subcellular localization of E2F-4 is cell-cycle dependent. Proc. Natl. Acad. Sci. USA 94:5095–5100
   PubMedGoogle Scholar
• Lukas, J., Petersen, B. O., Holm, K., Bartek, J., and Helin, K.. 1996. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16:1047–1057
   PubMed Web of Science ®Google Scholar
• Magae, J., Wu, C. L., Illenye, S., Harlow, E., and Heintz, N. H.. 1996. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci. 109:1717–1726
   PubMedGoogle Scholar
• Moberg, K., Starz, M. A., and Lees, J. A.. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436–1449
   PubMed Web of Science ®Google Scholar
• Morkel, M., Wenkel, J., Bannister, A. J., Kouzaridesand, T., and Hagemeier, C.. 1997. An E2F-like repressor of transcription. Nature 390:567–568
   PubMedGoogle Scholar
• Muller, H., Moroni, M. C., Vigo, E., Petersen, B. O., Bartek, J., and Helin, K.. 1997. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell. Biol. 17:5508–5520
   PubMedGoogle Scholar
• Nevins, J. R.. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9:585–593
   PubMedGoogle Scholar
• Pierce, A. M., Fischer, S. M., Conti, C. J., and Johnson, D. G.. 1998. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16:1267–1276
   PubMed Web of Science ®Google Scholar
• Pierce, A. M., Gimenez-Conti, I. B., Schneider-Broussard, R., Martinez, L. A., Conti, C. J., and Johnson, D. G.. 1998. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. USA 95:8858–8863
   PubMed Web of Science ®Google Scholar
• Pierce, A. M., Schneider-Broussard, R., Gimenez-Conti, I. B., Russell, J. L., Conti, C. J., and Johnson, D. J.. 1999. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol. Cell. Biol. 19:6408–6414
   PubMed Web of Science ®Google Scholar
• Pierce, A. M., Schneider-Broussard, R., Philhower, J. L., and Johnson, D. G.. 1998. Differential activities of E2F family members suggest unique functions in regulating transcription. Mol. Carcinog. 22:190–198
   PubMedGoogle Scholar
• Pomerantz, J., Schreiber-Agus, N., Liegeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., Cordon-Cardo, C., and DePinho, R. A.. 1998. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92:713–723
   PubMed Web of Science ®Google Scholar
• Quelle, D. E., Zindy, F., Ashman, R. A., and Sherr, C. J.. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993–1000
   PubMed Web of Science ®Google Scholar
• Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A.. 1986. Carcinogen specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78–80
   PubMed Web of Science ®Google Scholar
• Ramirez, A., Bravo, A., Jorcano, J. L., and Vida, M.. 1994. Sequences 5′ of the bovine keratin 5 gene direct tissue-and-cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58:53–64
   PubMed Web of Science ®Google Scholar
• Rodriquez-Puebla, M. L., LaCava, M., Gimenez-Conti, I. B., Johnson, D. J., and Conti, C. J.. 1998. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene 17:2251–2258
   PubMedGoogle Scholar
• Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., and Weinberg, R. A.. 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403–2407
   PubMedGoogle Scholar
• Sellers, W. R., Rodgers, J. W., Kaelin, W. G., and Livinston, D. M.. 1995. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA 92:11544–11548
   PubMed Web of Science ®Google Scholar
• Sherr, C. J.. 1996. Cancer cell cycles. Science 274:1672–1677
   PubMed Web of Science ®Google Scholar
• Sherr, C. J.. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984–2991
   PubMed Web of Science ®Google Scholar
• Trimarchi, J. M., Fairchild, B., Verona, R., Moberg, K., Andon, N., and Lees, J. A.. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95:2850–2855
   PubMed Web of Science ®Google Scholar
• Verona, R., Moberg, K., Estes, S., Starz, M., Vernon, J. P., and Lees, J. A.. 1997. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell. Biol. 17:7268–7282
   PubMed Web of Science ®Google Scholar
• Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar-Sagi, D.. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20–26
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., Chow, K. N., Luo, R. X., Zhang, S. H., He, S., and Dean, D. C.. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812–815
   PubMed Web of Science ®Google Scholar
• Xu, G., Livingston, D. M., and Krek, W.. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92:1357–1361
   PubMed Web of Science ®Google Scholar
• Zhang, Y., and Xiong, Y.. 1999. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell 3:579–591
   PubMed Web of Science ®Google Scholar